Angiotensin Amide

Angiotensin Amide

SCHEMBL9023554

CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C.c1c[nH]nn1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 10/20 0.68
AGTR1 P30556 2/20 0.68
REN P00797 2/20 0.64
TFPI P10646 4/20 0.55
NPY1R P25929 1/20 0.55
NPY2R P49146 1/20 0.55
NPY4R P50391 1/20 0.55
NPY5R Q15761 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Angiotensin Amide SCHEMBL9324 0.95 AGTR2 (0.74) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL8155919 0.95 AGTR2 (0.74) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL7337886 0.95 AGTR2 (0.73) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL9433448 0.95 AGTR2 (0.73) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Ii SCHEMBL7415391 0.95 AGTR2 (0.77) AGTR2AGTR1REN
Angiotensin Amide SCHEMBL2197068 0.94 AGTR2 (0.73) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL10495835 0.94 AGTR2 (0.72) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL23015107 0.94 AGTR2 (0.71) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL3850850 0.94 AGTR2 (0.71) AGTR2AGTR1RENNPY1RNPY2R
Angiotensin Amide SCHEMBL5722115 0.93 AGTR2 (0.75) AGTR2AGTR1RENTFPINPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0619819-B1 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-06-12 EP disclosed
EP-0508445-B1 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders SEARLE & CO (US) 1996-06-12 EP disclosed